Cargando…
Medication history-wide association studies for pharmacovigilance of pregnant patients
BACKGROUND: Systematic exclusion of pregnant people from interventional clinical trials has created a public health emergency for millions of patients through a dearth of robust safety data for common drugs. METHODS: We harnessed an enterprise collection of 2.8 M electronic health records (EHRs) fro...
Autores principales: | Challa, Anup P., Niu, Xinnan, Garrison, Etoi A., Van Driest, Sara L., Bastarache, Lisa M., Lippmann, Ethan S., Lavieri, Robert R., Goldstein, Jeffery A., Aronoff, David M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9481638/ https://www.ncbi.nlm.nih.gov/pubmed/36124058 http://dx.doi.org/10.1038/s43856-022-00181-w |
Ejemplares similares
-
Systematically Prioritizing Candidates in Genome-Based Drug Repurposing
por: Challa, Anup P., et al.
Publicado: (2019) -
Bronchopulmonary Dysplasia is Associated with Polyhydramnios in a Scan for Novel Perinatal Risk Factors
por: Campbell, Meredith S., et al.
Publicado: (2023) -
Pharmacovigilance of artemether-lumefantrine in pregnant women followed until delivery in Rwanda
por: Rulisa, Stephen, et al.
Publicado: (2012) -
Population genetic testing and SERPINA1 sequencing identifies unidentified alpha-1 antitrypsin deficiency alleles and gene-environment interaction with hepatitis C infection
por: Schuler, Bryce A., et al.
Publicado: (2023) -
Pharmacovigilance
por: Griffin, J. P.
Publicado: (1992)